Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer

Status unconfirmed

Conditions studied: Oral Squamous Cell Carcinoma

In brief

The purpose of this study is to verify the discriminatory value of previously identified salivary transcriptome and proteome markers for oral squamous cell cancer in an intended use population of patients with oral lesions suspicious for cancer.

Key facts

Study ID

NCT01587573

Run by

PeriRx

People needed

370

Starts

2012-04-01

Expected to finish

2018-12-01

Last updated by the study team

2018-04-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients scheduled for biopsy of an oral lesion suspicious for squamous cell cancer

You may not qualify if…

• Patients with known prior oral malignancy in last 2 years or other cancer in last 5 years other than non melanoma skin cancer or with immune deficiency

Where it is running

• St. John Providence Health System — Warren, Michigan, United States (enrolling)
• Main Line Health System — Wynnewood, Pennsylvania, United States (enrolling)
• University of Illinois at Chicago — Chicago, Illinois, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Department of Surgery, Michigan Sate University — East Lansing, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.